Dr. Rotem Laszlo Abraham Elgavish, MD, PhD

Dr. Elgavish practices at WakeMed Raleigh Campus in Raleigh, North Carolina, part of Advocate Health.

Dr. Elgavish's NPI, 1437366473, was assigned on May 17, 2007. Dr. Elgavish graduated from Heersink School of Medicine - Birmingham in 2003. Dr. Elgavish holds Colorado license DR.0054026.

Dr. Elgavish's primary practice is WakeMed Raleigh Campus, at 3000 New Bern Ave, Raleigh, NC 27610 in Wake County. The practice phone is (919) 350-8000.

Dr. Elgavish's primary practice is WakeMed Raleigh Campus in Raleigh, North Carolina, part of Advocate Health. Dr. Elgavish is also affiliated with UCHealth Memorial Hospital Central. The medical group on file is WakeMed Health & Hospitals. Dmand AI also links Dr. Elgavish to 4 more hospitals, 9 medical groups, 3 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elgavish practices, 10 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Elgavish's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Elgavish is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Elgavish's licenses on file in 15 states: Colorado, Georgia, Iowa, Illinois, North Carolina, North Dakota, Pennsylvania, Texas, Indiana, Oregon, California, District of Columbia, Maryland, Nebraska and Ohio.

Dmand AI lists epilepsy among the conditions Dr. Elgavish treats.

CMS data shows 234 Medicare services from Dr. Elgavish across 4 procedure codes in 2024, for 214 Medicare patients. Medicare paid $20,773 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 214 Medicare patients who saw Dr. Elgavish in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elgavish's median patient age at 69, with 53% women.

In 2024, Dr. Elgavish wrote 95 Medicare Part D claims for 16 patients. 88% of them were for generic drugs. CMS names the drug for 52 of them, across 2 drugs with 11 or more claims each, at $2,084 in total drug cost. In 2023, CMS named 46 claims across 2 drugs.

Dr. Elgavish accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Elgavish, published from 2011 to 2016. The most frequent topics are Brain, Electroencephalography and Epilepsy. Dr. Elgavish has published most often in Ann Neurol. Dr. Elgavish's most frequent co-authors are Robert C. Knowlton, MD, Jeffrey P. Blount, MD and Pongkiat Kankirawatana, MD.

CMS Open Payments shows 1,068 general payments to Dr. Elgavish from 47 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Sunovion Pharmaceuticals Inc. paid the most, $259,212.

Dr. Elgavish graduated from Heersink School of Medicine - Birmingham in 2003.

Dr. Elgavish is in network with 24 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.